Information Provided By:
Fly News Breaks for July 25, 2019
LMAT
Jul 25, 2019 | 08:36 EDT
Lake Street analyst Brooks O'Neil raised his price target for LeMaitre Vascular to $34 from $27 saying the company reported solid" Q2 results. The analyst, however, is hesitant to value the company at a premium to its peer group. He views the stock as fairly valued at current levels and keeps a Hold rating on the name.
News For LMAT From the Last 2 Days
There are no results for your query LMAT